|
Analytic and clinical validation of a negative prediction algorithm for actionable mutations utilizing genomic and epigenomic profiling in cfDNA. |
| |
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
Research Funding - Guardant Health |
Patents, Royalties, Other Intellectual Property - Guardant Health |
Travel, Accommodations, Expenses - Guardant Health |
| |
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
Research Funding - Guardant Health |
Patents, Royalties, Other Intellectual Property - Guardant Health |
Travel, Accommodations, Expenses - Guardant Health |
| |
|
Employment - Guardant Health; Myriad Genetics |
Stock and Other Ownership Interests - Guardant Health |
| |
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
| |
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
Patents, Royalties, Other Intellectual Property - US Patent App. 18/451,739 US Patent App. 17/162,897 |
| |
|
No Relationships to Disclose |
| |
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
Patents, Royalties, Other Intellectual Property - Guardant Health |
Travel, Accommodations, Expenses - Guardant Health |
| |
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
| |
|
Employment - Guardant Health |
Leadership - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
Patents, Royalties, Other Intellectual Property - Patents filed |